Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Overdose | 4 | 2023 | 154 | 1.730 |
Why?
|
| Analgesics, Opioid | 9 | 2022 | 501 | 1.590 |
Why?
|
| Opioid-Related Disorders | 4 | 2022 | 367 | 1.310 |
Why?
|
| Opiate Substitution Treatment | 2 | 2019 | 80 | 1.260 |
Why?
|
| Health Care Costs | 2 | 2023 | 171 | 1.050 |
Why?
|
| Text Messaging | 1 | 2023 | 18 | 0.900 |
Why?
|
| Health Expenditures | 1 | 2023 | 67 | 0.880 |
Why?
|
| Patients | 1 | 2022 | 53 | 0.860 |
Why?
|
| Femoral Artery | 1 | 2023 | 122 | 0.850 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 88 | 0.830 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 28 | 0.780 |
Why?
|
| Legislation, Drug | 1 | 2020 | 18 | 0.770 |
Why?
|
| Antiemetics | 1 | 2020 | 35 | 0.760 |
Why?
|
| Medical Oncology | 1 | 2020 | 102 | 0.720 |
Why?
|
| Criminals | 1 | 2019 | 26 | 0.670 |
Why?
|
| Veterans | 3 | 2024 | 629 | 0.650 |
Why?
|
| Serotonin Syndrome | 1 | 2018 | 7 | 0.640 |
Why?
|
| Pregnant Women | 1 | 2019 | 80 | 0.630 |
Why?
|
| Benzodiazepines | 1 | 2018 | 72 | 0.620 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 384 | 0.610 |
Why?
|
| Patient Compliance | 1 | 2019 | 249 | 0.610 |
Why?
|
| Phenols | 1 | 2018 | 120 | 0.570 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 247 | 0.540 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 415 | 0.520 |
Why?
|
| Humans | 24 | 2024 | 54246 | 0.430 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2023 | 251 | 0.320 |
Why?
|
| Chronic Pain | 2 | 2022 | 147 | 0.320 |
Why?
|
| Prevalence | 2 | 2023 | 1022 | 0.310 |
Why?
|
| Retrospective Studies | 8 | 2023 | 6432 | 0.310 |
Why?
|
| Cohort Studies | 3 | 2021 | 1543 | 0.270 |
Why?
|
| United States | 7 | 2023 | 5200 | 0.270 |
Why?
|
| Atherectomy | 1 | 2023 | 22 | 0.230 |
Why?
|
| Butylamines | 1 | 2023 | 3 | 0.230 |
Why?
|
| Lower Extremity | 1 | 2023 | 103 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 133 | 0.210 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 105 | 0.210 |
Why?
|
| Hospice Care | 1 | 2021 | 27 | 0.200 |
Why?
|
| Surgical Mesh | 1 | 2021 | 18 | 0.200 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 31 | 0.200 |
Why?
|
| Pregnancy | 2 | 2019 | 2620 | 0.200 |
Why?
|
| Vagina | 1 | 2021 | 47 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 1679 | 0.190 |
Why?
|
| Prosthesis Failure | 1 | 2021 | 113 | 0.190 |
Why?
|
| Nausea | 1 | 2020 | 52 | 0.190 |
Why?
|
| Fentanyl | 1 | 2020 | 34 | 0.190 |
Why?
|
| Vomiting | 1 | 2020 | 73 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2023 | 808 | 0.190 |
Why?
|
| Stents | 1 | 2023 | 375 | 0.180 |
Why?
|
| Female | 6 | 2021 | 28418 | 0.180 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 268 | 0.180 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 110 | 0.180 |
Why?
|
| Hospices | 1 | 2019 | 11 | 0.180 |
Why?
|
| Nonprescription Drugs | 1 | 2019 | 42 | 0.180 |
Why?
|
| Pain | 2 | 2024 | 405 | 0.170 |
Why?
|
| Alcoholism | 1 | 2022 | 249 | 0.170 |
Why?
|
| Reoperation | 1 | 2021 | 454 | 0.170 |
Why?
|
| Patient Care | 3 | 2023 | 61 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2023 | 282 | 0.170 |
Why?
|
| Prostate | 3 | 2023 | 117 | 0.160 |
Why?
|
| Insurance, Health | 1 | 2019 | 132 | 0.160 |
Why?
|
| Age Distribution | 1 | 2018 | 198 | 0.160 |
Why?
|
| Drug Interactions | 1 | 2018 | 206 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 89 | 0.150 |
Why?
|
| Adult | 5 | 2021 | 14182 | 0.150 |
Why?
|
| Risk Factors | 2 | 2023 | 3930 | 0.150 |
Why?
|
| Community Pharmacy Services | 1 | 2018 | 70 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2018 | 132 | 0.140 |
Why?
|
| Pharmacists | 1 | 2018 | 152 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2018 | 604 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2023 | 5604 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 331 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1056 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1033 | 0.120 |
Why?
|
| Aged | 4 | 2023 | 10041 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 3429 | 0.120 |
Why?
|
| SEER Program | 2 | 2023 | 91 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2018 | 451 | 0.110 |
Why?
|
| Male | 7 | 2023 | 27312 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1300 | 0.100 |
Why?
|
| Middle Aged | 4 | 2021 | 13070 | 0.100 |
Why?
|
| Time Factors | 1 | 2018 | 3212 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 1315 | 0.090 |
Why?
|
| Young Adult | 1 | 2018 | 4308 | 0.080 |
Why?
|
| Adolescent | 1 | 2018 | 6885 | 0.070 |
Why?
|
| New York | 1 | 2023 | 50 | 0.060 |
Why?
|
| Patient Participation | 1 | 2024 | 69 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2024 | 246 | 0.060 |
Why?
|
| Psychometrics | 1 | 2024 | 241 | 0.050 |
Why?
|
| Naloxone | 1 | 2022 | 61 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 135 | 0.050 |
Why?
|
| Medicare | 1 | 2023 | 240 | 0.050 |
Why?
|
| Narcotic Antagonists | 1 | 2022 | 127 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 273 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2021 | 158 | 0.050 |
Why?
|
| Registries | 1 | 2023 | 553 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 63 | 0.050 |
Why?
|
| Drug Tolerance | 1 | 2020 | 60 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 2021 | 73 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1304 | 0.040 |
Why?
|
| Palliative Care | 1 | 2021 | 188 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 36 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2019 | 74 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 765 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 538 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 49 | 0.040 |
Why?
|
| Professional Role | 1 | 2018 | 88 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 922 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 1361 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2019 | 349 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 683 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 327 | 0.030 |
Why?
|